Circulating inhibitor of factor VIII during treatment with teicoplanin and rifampicin.
D005169:Factor VIII / Q000037:antagonists & inhibitors*; D006020:Glycopeptides / Q000009:adverse effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D012293:Rifampin / Q000009:adverse effects*; D013203:Staphylococcal Infections / Q000188:drug therapy; D017334:Teicoplanin
D006020:Glycopeptides; D017334:Teicoplanin; D005169:Factor VIII; D012293:Rifampin